Skip to main content

Table 1 General Details Provided by PCPs on Referral Letters, %

From: Quality and continuity of information between primary care physicians and rheumatologists

Diagnosis Reason for referral Urgent Consult Needed Medical history Family history Medication history Employment history Relevant Laboratory Results
All patients n = 2430 98.9 8.7 55.2 16.1 56.9 12.8 51.2
Systemic inflammatory n = 745 99.2 14.0 56.6 18.7 62.8 12.8 66.0
 RA n = 120 99.2 20.8 52.5 20.0 70.8 13.3 76.7
 IA, other n = 167 100.0 13.8 53.9 19.2 63.5 18.0 72.5
 Crystal n = 122 100.0 13.1 64.8 16.4 76.2 11.5 50.0
 PMR n = 66 100.0 12.1 56.1 NR 65.2 NR 75.8
 SpA n = 76 97.4 11.8 51.3 17.1 46.1 17.1 52.6
 PsA n = 44 93.2 NR 63.6 13.6 50.0 13.6 56.8
 Other SARDsb n = 150 100.0 12.7 57.3 26.0 56.0 8.0 68.7
Osteoarthritis n = 787 98.4 5.2 48.4 15.4 53.8 13.5 45.1
Regional MSK syndromes n = 395 98.7 4.6 51.7 10.4 49.9 11.4 30.9
Chronic pain conditions n = 346 99.4 9.5 52.3 17.9 54.1 15.9 55.2
Osteoporosis/osteopenia n = 45 100.0 NR 73.3 13.3 80.0 NR 20.0
Other/miscellaneousa n = 112 98.2 10.7 67.0 20.5 64.3 7.1 67.9
  1. Abbreviations: RA rheumatoid arthritis, IA inflammatory arthritis, NR not reportable (to protect patient privacy), PMR polymyalgia rheumatica, SpA spondyloarthritis, PsA psoriatic arthritis, SARDs systemic autoimmune rheumatic diseases, MSK musculoskeletal
  2. aMiscellaneous referrals such as abnormal tests
  3. Values are the percentage with the denominator being the N within each diagnosis category
  4. bSARDs include lupus, vasculitis, scleroderma, Sjögren’s syndrome, dermatomyositis, polymyositis, Raynaud’s phenomenon, sarcoidosis, etc. (not defined in the previous categories)